REBECCA STRICKLAND: Open Payments
NPI 1699133256 · COVINGTON, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$469 in 22 payments from 12 companies in 2025. Trend: 2023 $191 · 2024 $130 · 2025 $469
Food & beverage: $469
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 4 | $84 |
| SANOFI-AVENTIS U.S. LLC | 3 | $73 |
| Lilly USA, LLC | 3 | $59 |
| Amgen Inc. | 3 | $52 |
| PFIZER INC. | 2 | $42 |
| Esperion Therapeutics, Inc. | 1 | $30 |
| Actelion Pharmaceuticals US, Inc. | 1 | $29 |
| Corcept Therapeutics | 1 | $23 |
| Dexcom, Inc. | 1 | $23 |
| Abbott Laboratories | 1 | $21 |
Products named: TZIELD, PREVNAR 20, MOUNJARO, Rybelsus, KRYSTEXXA, NEXLETOL, OPSUMIT, Ozempic.
Industry payments across GA — which companies pay providers there.
